On June 2, WuXi AppTec fell 3.12% in regular trading, trading at 123.1 HKD/share, with trading volume of 168 million HKD.
On the news front, the Life Sciences Tools and Services sector came under broad selling pressure, with peers declining in tandem. Morgan Stanley disclosed a significant reduction in its H-share long position from 7.72% to 4.27% on May 21, and the resulting selling overhang continues to weigh on sentiment. Despite the company aggressively repurchasing shares — spending approximately 155 million HKD on June 1 alone to buy back around 1.2 million H-shares, bringing total treasury shares to 5.16 million — the short-term selling pressure remains dominant.
Within the Life Sciences Tools and Services sector, the overall trend is notably weak. Among individual stocks, WuXi Bio down 2.37%, XtalPi down 2.64%, GenScript Bio down 2.30%, Insilico down 5.46%, WuXi XDC down 2.40%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments